Considering the important role of adiponectin in energy metabolism, agents that up-regulate adiponectin expression and production may benefit obesity, insulin resistance, type 2 diabetes and other related metabolic diseases. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.